drugset / Trial / NCT00377975

"Pecos" B-adrenergic and PPAR-G Stimulation Upregulates Lipid Metabolism in Human Subcutaneous Fat

NCT00377975

Phase 2 Completed 96 enrolled Pennington Biomedical Research Center
RandomizedParallel-groupDouble-blindTreatment

Summary

This study compares four treatments to see which one causes the most weight loss, fat loss, loss of abdominal fat and improvement in blood tests like cholesterol. The four treatments are: Placebo, Ephedrine plus caffeine, Pioglitazone, Combined pioglitazone and ephedrine plus caffeine

Timeline

Start
2003-01
Primary completion
Completion
2004-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Caffeine Small molecule
Subject Ephedrine Small molecule
Subject Pioglitazone Small molecule

Indications